Company Filing History:
Years Active: 2004-2007
Title: Innovations of Tomas Borje Leandersson
Introduction
Tomas Borje Leandersson is a notable inventor based in Staffanstorp, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic agents. With a total of 2 patents, his work focuses on innovative solutions for medical applications.
Latest Patents
Leandersson's latest patents include groundbreaking research on nuclear targeting by means of bacterial proteins. This patent describes a nuclear delivery construct that comprises protein H or a fragment capable of being targeted to the nucleus of a eukaryotic cell. Additionally, he has developed a method for using protein H as a cytostatic agent, particularly in the treatment of diseases characterized by undesired cell proliferation.
Career Highlights
Throughout his career, Leandersson has been associated with Hansa Medical AB, a company dedicated to advancing medical therapies. His work has been instrumental in exploring the therapeutic potential of bacterial proteins in oncology and other medical fields.
Collaborations
Leandersson has collaborated with esteemed colleagues, including Inga-Maria Frick and Lars H Björck. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to impactful discoveries.
Conclusion
Tomas Borje Leandersson's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His innovative approaches to medical treatments continue to pave the way for future advancements.